Fund comparison · from official SEC filings

BIB vs IBB: how much do they overlap?

ProShares Ultra Nasdaq Biotechnology and iShares Biotechnology ETF
Holdings overlap
53%
of assets, by weight
Shared positions
187
of 259 / 253 holdings
BIB expense ratio
0.95%
net, per year
IBB expense ratio
0.44%
net, per year
BIB and IBB are largely redundant — holding both means most of your money tracks the same underlying companies.
Shared holdings
Company
BIB
IBB
?
N/A
17.83%
0.00%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
6.77%
G
GILDGILEAD SCIENCES INC
5.19%
6.64%
A
AMGNAMGEN INC
4.99%
6.63%
R
REGNREGENERON PHARMACEUTICALS
3.57%
5.03%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
5.02%
A
ARGXARGENX SE - ADR
1.33%
2.78%
I
INSMINSMED INC
1.29%
2.61%
O
ONCBEONE MEDICINES LTD-ADR
0.51%
1.86%
B
BIIBBIOGEN INC
1.61%
1.80%
R
RVMDREVOLUTION MEDICINES INC
1.74%
0.66%
U
UTHRUNITED THERAPEUTICS CORP
1.36%
1.61%
I
INCYINCYTE CORP
1.08%
1.43%
I
ILMNILLUMINA INC
1.39%
1.24%
G
GMABGENMAB A/S -SP ADR
0.09%
1.22%
R
ROIVROIVANT SCIENCES LTD
1.20%
0.57%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
1.19%
M
MRNAMODERNA INC
1.04%
0.78%
M
MEDPMEDPACE HOLDINGS INC
0.71%
1.02%
E
EXELEXELIXIS INC
0.73%
0.94%
I
IONSIONIS PHARMACEUTICALS INC
0.71%
0.91%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.62%
0.90%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.64%
0.81%
A
ASNDASCENDIS PHARMA A/S
0.77%
0.74%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
0.20%
Only in BIB
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
?
Repurchase Agreement
3.50%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
V
VTRSVIATRIS INC
1.05%
G
GHGUARDANT HEALTH INC
0.95%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
S
SNYSANOFI-ADR
0.60%
A
ABVXABIVAX SA-ADR
0.46%
C
CAICARIS LIFE SCIENCES INC
0.26%
L
LGNDLIGAND PHARMACEUTICALS
0.26%
I
INDVINDIVIOR PHARMACEUTICALS INC
0.25%
A
AMRXAMNEAL PHARMACEUTICALS INC
0.23%
S
SUPNSUPERNUS PHARMACEUTICALS INC
0.15%
D
DFTXDEFINIUM THERAPEUTICS INC
0.13%
K
KODKODIAK SCIENCES INC
0.13%
K
KNSAKINIKSA PHARMACEUTICALS INTE
0.12%
O
OCULOCULAR THERAPEUTIX INC
0.11%
P
PHVSPHARVARIS NV
0.11%
S
SIONSIONNA THERAPEUTICS INC
0.11%
H
HRMYHARMONY BIOSCIENCES HOLDINGS
0.10%
A
ANIPANI PHARMACEUTICALS INC
0.10%
A
ATAIATAIBECKLEY INC
0.09%
I
INVAINNOVIVA INC
0.09%
G
GHRSGH RESEARCH PLC
0.08%
Only in IBB
B
BISXXBCF INSTITUTIONAL-SL AGNCY
11.65%
I
IQVIQVIA HOLDINGS INC
2.81%
M
MTDMETTLER-TOLEDO INTERNATIONAL
2.20%
N
NTRANATERA INC
1.87%
W
WATWATERS CORP
1.56%
T
TECHBIO-TECHNE CORP
0.75%
C
CRLCHARLES RIVER LABORATORIES
0.67%
R
RGENREPLIGEN CORP
0.62%
2
2GHMERUS NV
0.56%
V
VRNAVERONA PHARMA PLC - ADR
0.52%
?
Avidity Biosciences, Inc.
0.44%
A
ACLXARCELLX INC
0.30%
A
AKROAKERO THERAPEUTICS INC
0.29%
B
BRKRBRUKER CORP
0.29%
A
AM6AMICUS THERAPEUTICS INC
0.21%
1
1JKAPELLIS PHARMACEUTICALS INC
0.21%
?
89bio, Inc.
0.19%
X
XTSLABLCKRCK CASH-TRSRY-SL AGNCY
0.17%
B
BHVNBIOHAVEN LTD
0.12%
S
STVNSTEVANATO GROUP SPA
0.11%
D
DVAXDYNAVAX TECHNOLOGIES CORP
0.10%
R
RCUSARCUS BIOSCIENCES INC
0.08%
N
NUVBNUVATION BIO INC
0.07%
E
EVOEVOTEC SE - SPON ADR
0.07%
T
TRMLTOURMALINE BIO INC
0.07%
Hold BIB and IBB together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.